SEC Filings | Celldex Therapeutics

Form	Description	Filing date	View
SC 13G/A	An amendment to the SC 13G filing	Feb 14, 2017	View HTML 0000728889-17-000324.pdf 0000728889-17-000324.rtf 0000728889-17-000324.xls
424B3	Form of prospectus reflecting facts events constituting substantive change from last form	Feb 14, 2017	View HTML 0001104659-17-009252.pdf 0001104659-17-009252.rtf 0001104659-17-009252.xls
424B3	Form of prospectus reflecting facts events constituting substantive change from last form	Feb 14, 2017	View HTML 0001104659-17-009260.pdf 0001104659-17-009260.rtf 0001104659-17-009260.xls
EFFECT	EFFECT	Feb 13, 2017	View HTML 9999999995-17-000373.pdf 9999999995-17-000373.rtf 9999999995-17-000373.xls
EFFECT	EFFECT	Feb 13, 2017	View HTML 9999999995-17-000364.pdf 9999999995-17-000364.rtf 9999999995-17-000364.xls
SC 13G/A	An amendment to the SC 13G filing	Feb 10, 2017	View HTML 0000093751-17-000182.pdf 0000093751-17-000182.rtf
SC 13G/A	An amendment to the SC 13G filing	Feb 10, 2017	View HTML 0000932471-17-001145.pdf 0000932471-17-001145.rtf
SC 13G	A statement of beneficial ownership of common stock by certain persons	Feb 10, 2017	View HTML 0001193125-17-037281.pdf 0001193125-17-037281.rtf 0001193125-17-037281.xls
SC 13G/A	An amendment to the SC 13G filing	Feb 9, 2017	View HTML 0000038777-17-000142.pdf 0000038777-17-000142.rtf
S-3/A	Pre-effective amendment to an S-3 filing	Feb 9, 2017	View HTML 0001104659-17-007803.pdf 0001104659-17-007803.rtf 0001104659-17-007803.xls

Data provided by Kaleidoscope.